Government-Academic Partnerships in Randomized Evaluations: The Case of Inappropriate Prescribing
Adam Sacarny, David Yokum, Shantanu Agrawal
American Economic Review · 2017 · Volume 107 · Issue 5
Abstract
There is growing evidence that inappropriate prescribing is harming patients and raising costs in the US health care system. Through a partnership between the federal government and academics, we seek to develop evidence on reducing this prescribing. We conduct several randomized letter interventions targeting high-volume prescribers of drugs that can harm patients. We take a continuous improvement approach, rapidly evaluating each round and using the results to inform subsequent work. The first round of letters yielded no effects, and we responded with new interventions that are now under evaluation. We discuss lessons our work provides for future government-academic partnerships.
Keywords
National Government Expenditures and Health, Analysis of Health Care Markets, Health: Government Policy, Regulation, Public Health, Higher Education, Research Institutions, Chemicals, Plastics, Rubber, Drugs, Biotechnology
Enable JavaScript for citation tools and additional paper interactions.